There's a wave of therapeutic approaches to antibiotic resistance coming in the next 10-15 years, courtesy of CRISPR (gene editing broadly). We're going to end up having hundreds of new experimental angles of attack at resistance and infection. In fact, by far the bigger problem, is going to be narrowing down the vast array of options of attack that CRISPR is going to unleash.
These articles repeating the same hyped up fear, are missing what's right around the corner (which usually happens with such statements of doom, ala the world running out of food claims from decades ago). And best of all it's going to be inexpensive, relatively speaking, and extremely fast paced, to make progress in that direction. Cas9 and its superior alternatives such as Cpf1 arrived just in time.